DK1007040T3 - Anvendelsen af phanquinon til behandlingen af Alzheimers sygdom - Google Patents
Anvendelsen af phanquinon til behandlingen af Alzheimers sygdomInfo
- Publication number
- DK1007040T3 DK1007040T3 DK98930970T DK98930970T DK1007040T3 DK 1007040 T3 DK1007040 T3 DK 1007040T3 DK 98930970 T DK98930970 T DK 98930970T DK 98930970 T DK98930970 T DK 98930970T DK 1007040 T3 DK1007040 T3 DK 1007040T3
- Authority
- DK
- Denmark
- Prior art keywords
- alzheimer
- disease
- treatment
- phanquinone
- prevention
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GR97100330 | 1997-08-21 | ||
GR97100507 | 1997-12-31 | ||
PCT/IB1998/001095 WO1999009981A1 (en) | 1997-08-21 | 1998-07-17 | Use of phanquinone for the treatment of alzheimer's disease |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1007040T3 true DK1007040T3 (da) | 2002-08-26 |
Family
ID=26316681
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK98930970T DK1007040T3 (da) | 1997-08-21 | 1998-07-17 | Anvendelsen af phanquinon til behandlingen af Alzheimers sygdom |
Country Status (25)
Country | Link |
---|---|
US (2) | US6670369B1 (is) |
EP (1) | EP1007040B1 (is) |
JP (1) | JP2001513558A (is) |
CN (1) | CN1145482C (is) |
AT (1) | ATE217191T1 (is) |
AU (1) | AU741782B2 (is) |
BG (1) | BG64300B1 (is) |
BR (1) | BR9814945A (is) |
CA (1) | CA2301706C (is) |
CZ (1) | CZ299739B6 (is) |
DE (1) | DE69805305T2 (is) |
DK (1) | DK1007040T3 (is) |
EA (1) | EA002526B1 (is) |
ES (1) | ES2177024T3 (is) |
HK (1) | HK1029937A1 (is) |
HU (1) | HUP0004331A3 (is) |
IL (1) | IL134263A (is) |
IS (1) | IS1910B (is) |
NO (1) | NO317770B1 (is) |
NZ (1) | NZ502565A (is) |
PL (1) | PL191208B1 (is) |
PT (1) | PT1007040E (is) |
SK (1) | SK284708B6 (is) |
TR (1) | TR200000455T2 (is) |
WO (1) | WO1999009981A1 (is) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7045531B1 (en) | 1997-03-11 | 2006-05-16 | The General Hospital Corporation | Composition comprising a metal chelator and a method of treating amyloidosis by administering the metal chelator |
US5994323A (en) * | 1997-12-31 | 1999-11-30 | P.N. Gerolymatos S.A. | Pharmaceutical compositions comprising clioquinol in combination with vitamin B12 and therapeutic and prophylactic uses thereof |
US6323218B1 (en) | 1998-03-11 | 2001-11-27 | The General Hospital Corporation | Agents for use in the treatment of Alzheimer's disease |
US6638711B1 (en) | 1999-04-29 | 2003-10-28 | The General Hospital Corporation | Methods for identifying an agent that inhibits oxygen-dependent hydrogen peroxide formation activity but does not inhibit superoxide-dependent hydrogen peroxide formation |
ATE285235T1 (de) * | 1999-01-07 | 2005-01-15 | Gerolymatos P N Sa | Verwendung von phanquinon zur behandlung und vorbeugung von gedächtnisschwund |
WO2001082912A2 (en) * | 2000-04-28 | 2001-11-08 | Gerolymatos P N Sa | TREATMENT OF PATHOLOGICAL CONDITIONS INFLUENCED BY THE ACTION OF MATRIX METALLOPROTEINASES (MMPs) USING PHANQUINONE |
AU2001250571A1 (en) * | 2000-04-28 | 2001-11-12 | P.N. Gerolymatos S.A. | Treatment of pathological conditions influenced by the action of matrix metalloproteinases (mmps) using clioquinol |
EP1311299A4 (en) | 2000-08-18 | 2008-01-02 | Gen Hospital Corp | METHOD OF IDENTIFICATION AND USE OF SUBSTANCES WHICH CATEGORIZE OR PROMOTE CATARACTA |
FR2818551B1 (fr) * | 2000-12-22 | 2007-06-01 | Claude Marc Pierre Hannoun | Utilisation de chelateurs pour le traitement des maladies a prions |
AU2002950217A0 (en) | 2002-07-16 | 2002-09-12 | Prana Biotechnology Limited | 8- Hydroxy Quinoline Derivatives |
WO2004080208A1 (ja) * | 2003-03-11 | 2004-09-23 | Kaneka Corporation | コエンザイムq10を含有した水中油型乳化組成物、及びその製法 |
US20080207673A1 (en) * | 2005-05-04 | 2008-08-28 | Michel Xilinas | Method for Treating Cancer, Coronary, Inflammatory and Macular Disease, Combining the Modulation of Zinc-and/or Copper Dependent Proteins |
JP6692755B2 (ja) * | 2014-04-29 | 2020-05-13 | アフィリス・アクチェンゲゼルシャフトAffiris Ag | アルツハイマー病(ad)の処置および予防 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1617417A1 (de) * | 1966-12-08 | 1971-03-25 | Ciba Geigy | Pharmazeutisches Praeparat |
DE1804736A1 (de) * | 1967-11-02 | 1969-06-26 | Ciba Geigy | Pharmazeutisches Praeparat |
IL40311A (en) | 1972-09-06 | 1973-04-30 | Pharmaplantex Ltd | Pharmaceutical preparation for the treatment of gastro-intestinal troubles containing phanquone and furazolidone |
GB1472257A (en) | 1973-09-10 | 1977-05-04 | Christiaens Sa A | Derivative of 4-hydroxy-5-azacoumarin |
US5656286A (en) * | 1988-03-04 | 1997-08-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
US5719197A (en) * | 1988-03-04 | 1998-02-17 | Noven Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
US4981844A (en) * | 1988-10-04 | 1991-01-01 | University Of Cincinnati | Method to improve immune response and resistance to infection following surgery by diet composition |
US5091391A (en) * | 1990-08-16 | 1992-02-25 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Method of resisting neurodegenerative disorders |
US6165500A (en) * | 1990-08-24 | 2000-12-26 | Idea Ag | Preparation for the application of agents in mini-droplets |
AP387A (en) * | 1991-09-13 | 1995-07-31 | Siegbert Heinrich Bissbort | Therapeutical uses of L-methionine and compositions thereof. |
DE69227380T3 (de) | 1991-11-12 | 2007-01-11 | Prana Biotechnology Ltd., South Melbourne | Verfahren zur bestimmung und behandlung von alzheimer-krankheit |
GB9126874D0 (en) * | 1991-12-18 | 1992-02-19 | Wellcome Found | Medicaments |
AU6580494A (en) * | 1994-05-11 | 1995-12-05 | P.N. Gerolymatos S.A. | Use of clioquinol for treating helicobacter, including (h. pylori), infections and related diseases |
AU1153097A (en) * | 1996-06-07 | 1998-01-05 | Eisai Co. Ltd. | Stable polymorphs of donepezil (1-benzyl-4-{(5,6-dimethoxy-1-indanon)-2-yl}methylpiperidine ) hydrochloride and process for production |
HUP9903906A3 (en) * | 1996-08-13 | 2001-01-29 | Gerolymatos P N Sa | Use of chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease |
EP1007048A4 (en) | 1997-03-11 | 2004-09-22 | Gen Hospital Corp | IDENTIFICATION OF AGENTS USEFUL IN THE TREATMENT OF ALZHEIMER'S DISEASE |
US5980882A (en) * | 1997-04-16 | 1999-11-09 | Medeva Pharmaceuticals Manufacturing | Drug-resin complexes stabilized by chelating agents |
US5980914A (en) | 1997-08-22 | 1999-11-09 | P.N. Gerolymatos S.A. | Clioquinol for the treatment of Parkinson's disease |
US5994323A (en) | 1997-12-31 | 1999-11-30 | P.N. Gerolymatos S.A. | Pharmaceutical compositions comprising clioquinol in combination with vitamin B12 and therapeutic and prophylactic uses thereof |
ATE285235T1 (de) * | 1999-01-07 | 2005-01-15 | Gerolymatos P N Sa | Verwendung von phanquinon zur behandlung und vorbeugung von gedächtnisschwund |
WO2001082912A2 (en) | 2000-04-28 | 2001-11-08 | Gerolymatos P N Sa | TREATMENT OF PATHOLOGICAL CONDITIONS INFLUENCED BY THE ACTION OF MATRIX METALLOPROTEINASES (MMPs) USING PHANQUINONE |
AU2001250571A1 (en) | 2000-04-28 | 2001-11-12 | P.N. Gerolymatos S.A. | Treatment of pathological conditions influenced by the action of matrix metalloproteinases (mmps) using clioquinol |
-
1998
- 1998-07-17 DE DE69805305T patent/DE69805305T2/de not_active Expired - Fee Related
- 1998-07-17 CA CA002301706A patent/CA2301706C/en not_active Expired - Fee Related
- 1998-07-17 EA EA200000242A patent/EA002526B1/ru not_active IP Right Cessation
- 1998-07-17 IL IL134263A patent/IL134263A/en not_active IP Right Cessation
- 1998-07-17 ES ES98930970T patent/ES2177024T3/es not_active Expired - Lifetime
- 1998-07-17 WO PCT/IB1998/001095 patent/WO1999009981A1/en active IP Right Grant
- 1998-07-17 TR TR2000/00455T patent/TR200000455T2/xx unknown
- 1998-07-17 BR BR9814945-8A patent/BR9814945A/pt not_active Application Discontinuation
- 1998-07-17 JP JP2000507371A patent/JP2001513558A/ja active Pending
- 1998-07-17 AU AU81241/98A patent/AU741782B2/en not_active Ceased
- 1998-07-17 EP EP98930970A patent/EP1007040B1/en not_active Expired - Lifetime
- 1998-07-17 PL PL338673A patent/PL191208B1/pl not_active IP Right Cessation
- 1998-07-17 DK DK98930970T patent/DK1007040T3/da active
- 1998-07-17 US US09/485,909 patent/US6670369B1/en not_active Expired - Fee Related
- 1998-07-17 CN CNB988082926A patent/CN1145482C/zh not_active Expired - Fee Related
- 1998-07-17 CZ CZ20000611A patent/CZ299739B6/cs not_active IP Right Cessation
- 1998-07-17 AT AT98930970T patent/ATE217191T1/de not_active IP Right Cessation
- 1998-07-17 SK SK206-2000A patent/SK284708B6/sk not_active IP Right Cessation
- 1998-07-17 NZ NZ502565A patent/NZ502565A/en unknown
- 1998-07-17 HU HU0004331A patent/HUP0004331A3/hu unknown
- 1998-07-17 PT PT98930970T patent/PT1007040E/pt unknown
-
2000
- 2000-01-28 IS IS5366A patent/IS1910B/is unknown
- 2000-02-16 NO NO20000771A patent/NO317770B1/no not_active IP Right Cessation
- 2000-02-22 BG BG104179A patent/BG64300B1/bg unknown
-
2001
- 2001-02-07 HK HK01100873A patent/HK1029937A1/xx not_active IP Right Cessation
-
2003
- 2003-11-18 US US10/717,182 patent/US7629354B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS4972A (is) | Notkun klóbindiefnisins klíókínól við að framleiða lyfjablöndu til að meðhöndla Alzheimers-sjúkdóm | |
TR199902071T2 (xx) | Heterosiklik bile�ikler ve bunlar�n �-amilioid peptidinin inhibisyonunda kullan�m� | |
HUP9700603A1 (hu) | Gyógyászati készítmény véralvadási zavarok kezelésére | |
TR200002773T2 (tr) | Alzheimer tedavisi için smilagenin ve anzurogenin-D ve bunların kullanımı. | |
ATE334668T1 (de) | Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen | |
NO20022531D0 (no) | Vaksine for forebyggelse og behandling av Alzheimer og amyloidrelaterte sykdommer | |
DK1007040T3 (da) | Anvendelsen af phanquinon til behandlingen af Alzheimers sygdom | |
NO972391D0 (no) | 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav | |
NO20001869L (no) | FremgangsmÕte for behandling av Alzheimers sykdom | |
EA199700151A1 (ru) | Композиция для чрескожного введения | |
BR9711225A (pt) | Composi-{es de propentofilina transd-rmica para o tratamento do mal de alzheimer | |
DE69420229D1 (de) | Pharmazeutische Zusammensetzung zur Behandlung von AIDS | |
NO983177L (no) | Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft | |
TR200000291T2 (tr) | Taşikinin reseptör antagonistleri olarak 2-asilaminopropanaminler. | |
MX9707642A (es) | Uso de 2-oxoindol-1-carboxamidas 3-sustituidas y sus sales de base farmaceuticamente aceptables para preparar composiciones para el tratamiento y prevencion de la enfermedad de alzheimer en mamiferos, incluyendo a humanos. | |
PT1131297E (pt) | Certas caprolactamas substituidas composicoes farmaceuticas contendo-as e sua utilizacao no tratamento de tumores | |
PT888114E (pt) | Utilizacao de (+)-alfa-(2,3-dimetoxifenil)-1-¬2-(4-fluorofenil)etil|-4-piperidinometanol no tratamento de doencas depressivas e doencas bipolares | |
PT1152762E (pt) | Utilizacao de desoxipeganina no tratamento da demencia de alzheimer | |
DK0836853T3 (da) | Anvendelse af bradykinin-antagonister til fremstilling af lægemidler til behandling og forebyggelse af Alzheimers sygdom | |
DK0703781T3 (da) | Anvendelse af Efaroxan og derivater deraf til fremstilling af et lægemiddel til behandling af Parkinsons sygdom | |
NO953072L (no) | Anvendelse av inhibitorer av ornitinaminotransferase for fremstilling av et medikament for behandling av Alzheimers sykdom | |
RS49595B (sr) | Primena 2-fenil-1,2- benzizoselenazol-3(2h)-ona za izradu farmaceutskog preparata za lečenje alchajmerove bolesti | |
DK1152762T3 (da) | Anvendelse af desoxypeganin til behandling af Alzheimers demens |